Consent decree issued against recalcitrant compounder

The FDA has secured a consent decree against a Texas compounder that had questioned FDA authority over its operations. The FDA says that a federal judge issued the consent decree last week against Downing Labs of Dallas, co-owners Ashley Michelle Downing and Christopher Van Downing, and pharmacist-in-charge Roger Mansfield. Downing Labs, formerly known as NuVision Pharmacy, had continued to manufacture adulterated drugs even after repeated warnings from the FDA, the regulator said. The compounder, which had resisted FDA pressure to recall all of its sterile drugs, finally relented last fall. Release | More

Read more on